Citigroup Inc Arcturus Therapeutics Holdings Inc. Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Citigroup Inc holds 58,529 shares of ARCT stock, worth $677,765. This represents 0.0% of its overall portfolio holdings.
Number of Shares
58,529
Previous 19,615
198.39%
Holding current value
$677,765
Previous $455,000
118.24%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ARCT
# of Institutions
167Shares Held
25.9MCall Options Held
163KPut Options Held
173K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$54.4 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$30.7 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$23.9 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$23.9 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$22.4 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $308M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...